🔎 Trials Near Me

Dachaigh › Cancer Ovarian › Pennsylvania

Sgrùdaidhean clionaigeach Cancer Ovarian ann an Pennsylvania

Tha 69 sgrùdaidhean airson Cancer Ovarian a’ lorg phàirtichean aig làraichean ann an Pennsylvania.

Bailtean ann an Pennsylvania

Teacsa sgrùdaidh oifigeil (Beurla)

Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity

  • Thomas Jefferson University Hospital, Philadelphia
  • UPMC Hillman Cancer Center, Pittsburgh
  • UPMC-Passavant Hospital, Pittsburgh
A’ fastadhÌre 2/3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT07001748

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

  • Lehigh Valley Hospital-Cedar Crest, Allentown
  • UPMC Altoona, Altoona
  • Lehigh Valley Hospital - Muhlenberg, Bethlehem
  • agus 18 a bharrachd
A’ fastadhÌre 2
Gach aois · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT05564377

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

  • Abramson Cancer Center of the University of Pennsylvania, Philadelphia
  • University of Pittsburgh Medical Center, Pittsburgh
  • WellSpan York Cancer Center, York
A’ fastadhÌre 1/2
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT04585750

Distance-Based Exercise to Preserve Function and Prevent Disability

  • UPMC Hillman Cancer Center at Butler Health System, Butler
  • IRMC Cancer Center, Indiana
  • UPMC Hillman Cancer Center - New Castle, New Castle
  • agus 2 a bharrachd
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT07059884

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

  • Sidney Kimmell Cancer Center - Jefferson Health, Philadelphia
A’ fastadhÌre 1
Aoisean 19 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT06586957

Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study

  • University of Pennsylvania, Philadelphia
A’ fastadh
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 29 Sult 2026 · NCT05287451

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

  • Research Site, Pittsburgh
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 29 Sult 2026 · NCT05877599

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

  • St. Lukes University Hospital /ID# 274362, Bethlehem
  • University of Pennsylvania - Perelman Center for Advanced Medicine /ID# 275612, Philadelphia
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 29 Sult 2026 · NCT06890338

A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer

  • Site 0232 - University of Pennsylvania, Philadelphia
  • Site 0178 - Thomas Jefferson University, Philadelphia
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 29 Sult 2026 · NCT05128825

Study of AVZO-021 in Patients With Advanced Solid Tumors

  • Avenzo Therapeutics Recruiting Site, Philadelphia
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT05867251

DESTINY-PANTUMOUR04

  • Research Site, Philadelphia
A’ fastadhSgrùdadh amharc
Aoisean 18 gu 130 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07124000

A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab

  • Perelman School of Medicine at the University of Pennsylvania, Philadelphia
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 24 Sult 2026 · NCT04590326

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

  • University of Pennsylvania Hospital, Philadelphia
  • Jefferson Health Honickman Center, Philadelphia
  • Asplundh Cancer Pavilion, Willow Grove
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07213804

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

  • University of Pennsylvania, Philadelphia
  • Fox Chase Cancer Center, Philadelphia
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07213791

A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer

  • Penn Medicine University of Pennsylvania Health System /ID# 277963, Philadelphia
  • Western Pennsylvania Gynecologic Oncology /ID# 278632, Pittsburgh
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 22 Sult 2026 · NCT07059845

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

  • Allegheny Health Network, Pittsburgh
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT06128551

Prehabilitation in High-risk Oncologic Surgery

  • Fox Chase Cancer Center - Philadelphia, Philadelphia
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 21 Sult 2026 · NCT07638410

BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)

  • University of Pennsylvania, Philadelphia
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Sult 2026 · NCT04752826

A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)

  • Hospital of the University of Pennsylvania ( Site 0071), Philadelphia
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 17 Sult 2026 · NCT07318558

Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

  • University of Pittsburgh Cancer Institute Cancer Services, Pittsburgh
  • Allegheny Health Network- West Penn Hospital, Pittsburgh
  • Lankenau Medical Center, Wynnewood
  • agus 1 a bharrachd
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 15 Sult 2026 · NCT07214779

A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

  • Penn State College of Medicine, Hershey
A’ fastadhÌre 2
Aoisean 18 gu 99 · Banairean · Air ùrachadh 15 Sult 2026 · NCT07023627

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

  • University of Pennsylvania, Philadelphia
  • WellSpan Medical Oncology & Hematology at York Cancer Center, York
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 14 Sult 2026 · NCT05059444

Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer

  • University of Pittsburgh Medical Center, Magee-Womens Hospital, Pittsburgh
  • West Penn Hospital of Allegheny Health Network, Pittsburgh
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 14 Sult 2026 · NCT06787612

FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC

  • Allegheny Singer, Pittsburgh
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 14 Sult 2026 · NCT06303505

Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial

  • St. Luke's University Health Network, Bethlehem
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 14 Sult 2026 · NCT04575935

A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies

  • Research Site, Pittsburgh
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 11 Sult 2026 · NCT05123482

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

  • Allegheny Health Network West Penn Hospital ( Site 0099), Pittsburgh
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 3 Sult 2026 · NCT06824467

FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors

  • Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Sult 2026 · NCT07216105

Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors

  • UPMC Hillman Cancer Center, Pittsburgh
A’ fastadhÌre 1
Aoisean 15 agus nas sine · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT06276491

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

  • Children's Hospital of Philadelphia, Philadelphia
  • Children's Hospital of Pittsburgh of UPMC, Pittsburgh
A’ fastadhÌre 1/2
12 Months – 30 Years · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT04851119

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

  • Sidney Kimmel Comprehensive Center at Jefferson, Philadelphia
  • UPMC, Pittsburgh
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 21 Lùna 2026 · NCT06774963

A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.

  • SCRI - Sydney Kimmel Cancer Center - Jefferson Health, Philadelphia
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Lùna 2026 · NCT07470853

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

  • Normunity Investigational Site, Philadelphia
  • Normunity Investigational Site, Philadelphia
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Lùna 2026 · NCT07182149

The Appendix Cancer PMP Research Foundation Natural History Study/Patient Registry

  • ACPMP, Springfield
A’ fastadhSgrùdadh amharc
Gach aois · Gach gnè · Air ùrachadh 17 Lùna 2026 · NCT07769346

A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression

  • Site 0109, Philadelphia
  • Site 0113, Philadelphia
  • Site 0114, Willow Grove
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 12 Lùna 2026 · NCT07546500

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

  • Jefferson Abington Hospital, Abington
  • Christiana Care Health System-Concord Health Center, Chadds Ford
  • Penn State Milton S Hershey Medical Center, Hershey
  • agus 15 a bharrachd
A’ fastadh
Aoisean 35 gu 50 · Banairean · Air ùrachadh 7 Lùna 2026 · NCT04251052

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

  • Lehigh Valley Hospital-Cedar Crest, Allentown
  • Saint Luke's Cancer Center - Allentown, Allentown
  • Saint Luke's University Hospital-Bethlehem Campus, Bethlehem
  • agus 21 a bharrachd
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 7 Lùna 2026 · NCT06580314

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

  • USOR Alliance Cancer Specialist, Doylestown
  • Allegheny Health Network, Pittsburgh
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 4 Lùna 2026 · NCT05579366

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

  • University of Pennsylvania / Abramson Cancer Center, Philadelphia
  • Thomas Jefferson University, Sidney Kimmel Cancer Center, Clinical Research Organization, Philadelphia
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Iuch 2026 · NCT04657068

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.